SYNT
LIVE

Serial Number

99245099

Owner

Syntis Bio, Inc.

Attorney

Sara M. Bauer

Filing Date

Jun 20, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SYNT Trademark

Serial Number: 99245099

SYNT is a trademark filed by Syntis Bio, Inc. on June 20, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Syntis Bio, Inc. (2 trademarks)

135 Morrisey Boulevard
Boston, MA 02125

Entity Type: 03

Trademark Details

Filing Date

June 20, 2025

Registration Date

Not Registered

Published for Opposition

March 3, 2026

Goods & Services

Pharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations for the treatment of weight gain and obesity; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, and degenerative conditions associated with aging; Pharmaceutical preparations for the treatment and prevention of chronic diseases, conditions, and functional disorders, namely, Alzheimer's Disease, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, metabolic diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; Pharmaceutical preparations for the treatment and prevention of chronic metabolic diseases, metabolic conditions, and functional neurological disorders; Biological preparations for the treatment of metabolic diseases and disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 28, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 25, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 10, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 10, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 10, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 10, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 10, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 20, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 20, 2025 NWOS
NEW APPLICATION ENTERED
Jun 20, 2025 NWAP